Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19 | 174 | 85 | 873 | 0 |
| TOTAL | $19 | $174 | $85 | $873 | $0 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 0 | 0 | 65 |
| Other Non-Current Assets | 0 | 4 | 4 | 4 | 0 |
| TOTAL | $N/A | $4 | $4 | $4 | $65 |
| Total Assets | $19 | $177 | $89 | $877 | $65 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,500 | 18 | 11 | 6 | 0 |
| Accrued Expenses | 38 | 38 | N/A | N/A | N/A |
| TOTAL | $6,538 | $57 | $2,061 | $10,006 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 6,500 | 6,500 | 0 | 0 |
| TOTAL | $N/A | $6,500 | $6,500 | $N/A | $N/A |
| Total Liabilities | $6,538 | $6,557 | $8,561 | $10,006 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,172 | N/A | 1,164 | 1,161 | 1,160 |
| Common Shares | 211 | 211 | 209 | 209 | 65 |
| Retained earnings | -11,534 | -11,323 | -10,669 | -10,426 | -46 |
| TOTAL | $-6,520 | $-6,379 | $-8,473 | $-9,129 | $65 |
| Total Liabilities And Equity | $19 | $177 | $89 | $876 | $65 |